Senior insider sale
President and CEO at TAKEDA PHARMACEUTICAL CO LTD — senior position signals high conviction
$196.3K
14.89K shares
What this filing means
WEBER CHRISTOPHE PIERRE plans to sell 14.89K shares of TAKEDA PHARMACEUTICAL CO LTD valued at approximately $196.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/10/2024ACC: 0001395064-24-000140
DirectorOfficer· President and CEO
Since Mar 2026
14.89K
Shares to sell
$196.3K
Approx. market value
29.33K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit Awards - Vested.
Compensation
7/1/2024
29.33KTotal acquired29.33K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/1/2024 | Restricted Stock Unit Awards - Vested. Compensation | 29.33K | — |
| Total | 29.33K | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
14.89K
Market value
$196.3K
7/11/2024
Total
Units
14.89K
Value
$196.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/11/2024 | 14.89K | $196.3K | NYSE | Planned |
| Total | 14.89K | $196.3K | ||